LYEL
Lyell Immunopharma Inc.
$13.09
+$0.45(+3.56%)
56
Overall
--
Value
58
Tech
55
Quality
Market Cap
$253.97M
Volume
279.29K
52W Range
$7.65 - $32.00
Target Price
$11.00
Key Metrics Overview
| Market Cap | $253.97M | P/E Ratio | N/A |
| 52W High | $32.00 | 52W Low | $7.65 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 67.1% | 52W Position | 22.3% |
| Overall Score | 56 | Value Score | -- |
| Quality Score | 55 | Technical Score | 58 |
Growth Analysis
| EPS Current Est | $-13.15 | EPS Next Est | $-13.6 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LYEL | $13.09 | +3.6% | 279.29K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |